Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies

Schizophrenia Bulletin
H Y Meltzer

Abstract

Autoreceptors are those receptors located on neuronal bodies, dendrites, and nerve terminals, which respond to the neurotransmitter released by that neuron, and contribute to the regulation of the synthesis and release of the neurotransmitter itself. Autoreceptors have been identified on the neurons of the nigrostriatal and mesolimbic dopaminergic neurons. Stimulation of these autoreceptors by dopamine agonists decreases dopaminergic activity. Preliminary clinical studies suggest that administration of low doses of conventional dopamine agonists such as apomorphine can inhibit the activity of some dopaminergic neurons and be of therapeutic use in the treatment of excited psychotic states and a variety of abnormal movement disorders. Specific autoreceptor agonists and antagonists may prove to be of considerable clinical and theoretical importance in psychiatry. This article reviews the major preclinical and clinical research on dopamine autoreceptors.

Citations

Jan 1, 1995·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O BenkertH Wetzel
Feb 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A MucciM Maj
Sep 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M G FeenstraA S Horn
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·J H Meador-WoodruffS J Watson
Feb 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S KasperH Pfolz
Jan 5, 2012·Neurotoxicity Research·Carlos J BaierMarta C Antonelli
Jul 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·H Wetzel, O Benkert
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Lal
Jan 1, 1995·Acta Psychiatrica Scandinavica. Supplementum·W W Fleischhacker
May 1, 1988·Psychiatry Research·G M BrownJ Mitton
Jul 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·S HjorthB Andersson
Mar 1, 1986·Pharmacology, Biochemistry, and Behavior·E VasarL Allikmets
Feb 1, 1986·Pharmacology, Biochemistry, and Behavior·S HjorthA Carlsson
Jan 1, 1990·Annals of the New York Academy of Sciences·M E Wolf, R H Roth
Jan 1, 1990·Annals of the New York Academy of Sciences·H Y Meltzer
Jun 1, 1988·The Journal of Pharmacy and Pharmacology·D T Manallack, P M Beart
Jun 30, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Milky KohnoEdythe D London
May 25, 2015·Brain Research Bulletin·Xiaofan ZhangGrainne Mary McAlonan
Apr 4, 2017·ACS Chemical Neuroscience·Austen B Casey, Clinton E Canal
Apr 1, 1985·Medicinal Research Reviews·C Kaiser, T Jain
Dec 1, 1986·The Japanese Journal of Psychiatry and Neurology·I MatsuokaG Ikawa
Apr 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·I N FerrierT J Crow
Jul 1, 1987·Medicinal Research Reviews·P B Timmermans, M J Thoolen
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·E K SyvälahtiJ Hietala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here